Thiolated human serum albumin cross-linked dextran hydrogels as a macroscale delivery system
Source abstract
Abstract
Hydrogels play an important role in macroscale delivery systems by enabling the transport of cells and molecules. Here we present a facile and benign method to prepare a dextran-based hydrogel (Dex-sHSA) using human serum albumin (HSA) as a simultaneous drug carrier and covalent cross-linker. Drug binding affinity of the albumin protein was conserved in the thiolation step using 2-iminothiolane and subsequently, in the in situ gelation step. Oscillation rheometry studies confirmed the formation of a three-dimensional viscoelastic network upon reaction of dextran and the HSA protein. The mechanical properties of Dex-sHSA hydrogel can be tuned by the protein concentration, and the degree of thiolation of sHSA. Sustained release of hydrophobic drugs, such as ibuprofen, paclitaxel and dexamethasone, from the Dex-sHSA network was shown over one week. Hence, this albumin-based dextran hydrogel system demonstrates its potential as a macroscale delivery system of hydrophobic therapeutics for a wide range of biomedical applications.
Source: openalex_inverted_index · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Hydrogels: synthesis, properties, applications · Advanced Drug Delivery Systems · Nanoparticle-Based Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Leiden Institute of Chemistry
Leiden University
2300 RA Leiden, The Netherlands
Department of Chemical Engineering
TU Delft
2628 BL Delft, The Netherlands
References (55)
Show source-provided references
1. Kearney · Nat. Mater. · 2013 · 12 · 100410.1038/nmat3758 ↗
2. Kharkar · Chem. Soc. Rev. · 2013 · 42 · 733510.1039/C3CS60040H ↗
3. Uhrich · Chem. Rev. · 1999 · 99 · 318110.1021/cr940351u ↗
4. Censi · Biomacromolecules · 2010 · 11 · 214310.1021/bm100514p ↗
5. Pescosolido · Soft Matter · 2012 · 8 · 770810.1039/c2sm25677k ↗
6. Dhanasingh · Soft Matter · 2012 · 8 · 164310.1039/C1SM06603J ↗
7. Zustiak · Soft Matter · 2010 · 6 · 360910.1039/c0sm00111b ↗
8. Lin · Adv. Drug Delivery Rev. · 2006 · 58 · 137910.1016/j.addr.2006.09.004 ↗
9. Moghadam · Biomaterials · 2014 · 35 · 45010.1016/j.biomaterials.2013.09.065 ↗
10. Schillemans · Eur. J. Pharm. Biopharm. · 2010 · 76 · 32910.1016/j.ejpb.2010.08.001 ↗
11. Kiick · Soft Matter · 2008 · 4 · 2910.1039/B711319F ↗
12. Binauld · Chem. Commun. · 2013 · 49 · 208210.1039/c2cc36589h ↗
13. Yamaguchi · Biomacromolecules · 2005 · 6 · 192110.1021/bm050003+ ↗
14. Fairbanks · Macromolecules · 2011 · 44 · 244410.1021/ma200202w ↗
15. Kloxin · Nat. Protoc. · 2010 · 5 · 186710.1038/nprot.2010.139 ↗
16. Tibbitt · Macromolecules · 2013 · 46 · 278510.1021/ma302522x ↗
17. Peng · Chem. Commun. · 2010 · 46 · 409410.1039/c002565h ↗
18. Peng · Soft Matter · 2011 · 7 · 488110.1039/c1sm05291h ↗
19. Tomatsu · Adv. Drug Delivery Rev. · 2011 · 63 · 125710.1016/j.addr.2011.06.009 ↗
20. Wang · Macromol. Biosci. · 2011 · 11 · 32110.1002/mabi.201000206 ↗
21. Mullarney · Polymer · 2006 · 47 · 384510.1016/j.polymer.2006.03.096 ↗
22. Liu · Biomaterials · 2006 · 27 · 401610.1016/j.biomaterials.2006.02.042 ↗
23. Hoare · Polymer · 2008 · 49 · 199310.1016/j.polymer.2008.01.027 ↗
24. Thatiparti · Biomaterials · 2010 · 31 · 233510.1016/j.biomaterials.2009.11.087 ↗
25. Zhou · Polym. Chem. · 2010 · 1 · 155210.1039/c0py00219d ↗
26. Peng · Soft Matter · 2010 · 6 · 377810.1039/c0sm00096e ↗
27. Peng · Soft Matter · 2010 · 6 · 8510.1039/B914166A ↗
28. Liu · RSC Adv. · 2013 · 3 · 2504110.1039/c3ra42532k ↗
29. Cai · Soft Matter · 2012 · 8 · 561210.1039/c2sm25368b ↗
30. Singh · Ind. Eng. Chem. Res. · 2011 · 50 · 1374210.1021/ie200758b ↗
31. Salian · Macromol. Chem. Phys. · 2013 · 214 · 235510.1002/macp.201300386 ↗
32. T. Heimbach , D.Fleisher and A.Kaddoumi, in Prodrugs, ed. V. Stella, R. Borchardt, M. Hageman, R. Oliyai, H. Maag and J. Tilley, Springer, New York, 2007, vol. V, pp. 157–21510.1007/978-0-387-49785-3_5 ↗
33. Kratz · J. Controlled Release · 2008 · 132 · 17110.1016/j.jconrel.2008.05.010 ↗
34. He · Nature · 1992 · 358 · 20910.1038/358209a0 ↗
35. Hirose · Mater. Sci. Eng., C · 2010 · 30 · 66410.1016/j.msec.2010.02.020 ↗
36. Kakinoki · Eur. J. Pharm. Biopharm. · 2007 · 66 · 38310.1016/j.ejpb.2006.11.022 ↗
37. Tada · Mater. Sci. Eng., C · 2007 · 27 · 87010.1016/j.msec.2006.10.008 ↗
38. Tada · J. Biosci. Bioeng. · 2005 · 100 · 55110.1263/jbb.100.551 ↗
39. Oss-Ronen · Adv. Eng. Mater. · 2010 · 12 · B4510.1002/adem.200980005 ↗
40. Oss-Ronen · Acta Biomater. · 2011 · 7 · 16310.1016/j.actbio.2010.07.017 ↗
41. El-Sherif · J. Appl. Polym. Sci. · 2010 · 115 · 205010.1002/app.31301 ↗
42. de Figueiredo · Synthesis · 2008 · 1316
43. Moore · Macromolecules · 1990 · 23 · 6510.1021/ma00203a013 ↗
44. Vandijkwolthuis · Macromolecules · 1995 · 28 · 631710.1021/ma00122a044 ↗
45. Ahmad · Biomacromolecules · 2006 · 7 · 135010.1021/bm050996b ↗
46. Manjappa · J. Controlled Release · 2011 · 150 · 210.1016/j.jconrel.2010.11.002 ↗
47. Weber · Int. J. Pharm. · 2000 · 211 · 6710.1016/S0378-5173(00)00590-1 ↗
48. Kelly · Biochim. Biophys. Acta, Proteins Proteomics · 2005 · 1751 · 11910.1016/j.bbapap.2005.06.005 ↗
49. Dockal · J. Biol. Chem. · 1999 · 274 · 2930310.1074/jbc.274.41.29303 ↗
50. Dockal · J. Biol. Chem. · 2000 · 275 · 304210.1074/jbc.275.5.3042 ↗
51. Antonov · Biomacromolecules · 2005 · 6 · 298010.1021/bm050279h ↗
52. Nair · Chem. Mater. · 2013 · 26 · 72410.1021/cm402180t ↗
53. Valko · J. Pharm. Sci. · 2003 · 92 · 223610.1002/jps.10494 ↗
54. Singla · Int. J. Pharm. · 2002 · 235 · 17910.1016/S0378-5173(01)00986-3 ↗
55. Waters · J. Pharm. Sci. · 2008 · 97 · 458610.1002/jps.21317 ↗